PL369294A1 - Granulaty zawierające substancje rozpuszczalne w tłuszczach i sposób ich wytwarzania - Google Patents

Granulaty zawierające substancje rozpuszczalne w tłuszczach i sposób ich wytwarzania

Info

Publication number
PL369294A1
PL369294A1 PL02369294A PL36929402A PL369294A1 PL 369294 A1 PL369294 A1 PL 369294A1 PL 02369294 A PL02369294 A PL 02369294A PL 36929402 A PL36929402 A PL 36929402A PL 369294 A1 PL369294 A1 PL 369294A1
Authority
PL
Poland
Prior art keywords
preparation
granulates
water
substances
granulates containing
Prior art date
Application number
PL02369294A
Other languages
English (en)
Other versions
PL204963B1 (pl
Inventor
Alberto Reiner
Original Assignee
Apr Applied Pharma Research Sa
Fidia Farmaceutici S.P.A.
Ipsen Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apr Applied Pharma Research Sa, Fidia Farmaceutici S.P.A., Ipsen Spa filed Critical Apr Applied Pharma Research Sa
Publication of PL369294A1 publication Critical patent/PL369294A1/pl
Publication of PL204963B1 publication Critical patent/PL204963B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
PL369294A 2001-07-11 2002-07-09 Sposób wytwarzania granulatu, granulat, kompozycja farmaceutyczna zawierająca go oraz sposób wytwarzania wodnej dyspersji PL204963B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01202657A EP1275377B1 (en) 2001-07-11 2001-07-11 Granulates containing liposoluble substances and process of preparation thereof

Publications (2)

Publication Number Publication Date
PL369294A1 true PL369294A1 (pl) 2005-04-18
PL204963B1 PL204963B1 (pl) 2010-02-26

Family

ID=8180628

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369294A PL204963B1 (pl) 2001-07-11 2002-07-09 Sposób wytwarzania granulatu, granulat, kompozycja farmaceutyczna zawierająca go oraz sposób wytwarzania wodnej dyspersji

Country Status (21)

Country Link
US (1) US7615547B2 (pl)
EP (1) EP1275377B1 (pl)
JP (1) JP2004536118A (pl)
KR (1) KR100877628B1 (pl)
AT (1) ATE243028T1 (pl)
AU (1) AU2002328866B2 (pl)
BR (1) BR0211081A (pl)
CA (1) CA2452386C (pl)
DE (1) DE60100389T2 (pl)
DK (1) DK1275377T3 (pl)
ES (1) ES2199202T3 (pl)
HR (1) HRP20040010A2 (pl)
IL (1) IL159346A0 (pl)
MX (1) MXPA04000211A (pl)
NO (1) NO20040043L (pl)
NZ (1) NZ530473A (pl)
PL (1) PL204963B1 (pl)
PT (1) PT1275377E (pl)
RU (1) RU2288704C2 (pl)
WO (1) WO2003005989A2 (pl)
ZA (1) ZA200309680B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080486A1 (en) 2000-11-29 2005-04-14 Fallin T. Wade Facet joint replacement
US6579319B2 (en) 2000-11-29 2003-06-17 Medicinelodge, Inc. Facet joint replacement
US6419703B1 (en) 2001-03-01 2002-07-16 T. Wade Fallin Prosthesis for the replacement of a posterior element of a vertebra
US7090698B2 (en) 2001-03-02 2006-08-15 Facet Solutions Method and apparatus for spine joint replacement
US8926700B2 (en) 2003-12-10 2015-01-06 Gmedelware 2 LLC Spinal facet joint implant
US7507242B2 (en) 2004-06-02 2009-03-24 Facet Solutions Surgical measurement and resection framework
WO2007067208A1 (en) * 2005-12-09 2007-06-14 Teva Pharmaceutical Industries Ltd. Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation
JP5484910B2 (ja) * 2006-12-22 2014-05-07 ユーハン・コーポレイション レバプラザン含有の固体分散体及びその製造方法
CN106635949B (zh) * 2011-12-22 2020-05-19 生命技术公司 细胞培养基和方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3068088C (en) * 2017-06-23 2024-01-23 Medcan Pharma A/S Cannabinoid pouch
CN108309933A (zh) * 2018-03-19 2018-07-24 青岛国海生物制药有限公司 一种口服醋酸甲地孕酮纳米混悬液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610037A1 (de) * 1986-03-21 1987-09-24 Schering Ag Nifedipinkombinationspraeparat
JPH0449232A (ja) 1990-06-15 1992-02-18 Fujisawa Pharmaceut Co Ltd 懸濁用組成物または懸濁液並びにそれらの製造法
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
AU678303B2 (en) 1993-10-01 1997-05-22 Syntex (U.S.A.) Inc. Mycophenolate mofetil high dose oral suspensions
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
FR2730163B1 (fr) 1995-02-03 1997-04-04 Jouveinal Lab Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
AU1939797A (en) 1996-03-14 1997-10-01 Shionogi & Co., Ltd. Rapid-release microdispersible ecadotril preparation
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
WO2000030616A1 (en) 1998-11-20 2000-06-02 Rtp Pharma Inc. Dispersible phospholipid stabilized microparticles
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form

Also Published As

Publication number Publication date
BR0211081A (pt) 2004-12-14
NO20040043L (no) 2004-01-06
MXPA04000211A (es) 2005-03-07
WO2003005989A2 (en) 2003-01-23
US20040009232A1 (en) 2004-01-15
HRP20040010B1 (pl) 2007-01-31
ATE243028T1 (de) 2003-07-15
WO2003005989A3 (en) 2003-05-01
DK1275377T3 (da) 2003-10-06
RU2288704C2 (ru) 2006-12-10
KR100877628B1 (ko) 2009-01-07
PL204963B1 (pl) 2010-02-26
AU2002328866B2 (en) 2007-02-15
DE60100389T2 (de) 2004-05-19
JP2004536118A (ja) 2004-12-02
US7615547B2 (en) 2009-11-10
PT1275377E (pt) 2003-11-28
CA2452386C (en) 2011-01-18
RU2004103853A (ru) 2005-03-27
IL159346A0 (en) 2004-06-01
EP1275377A1 (en) 2003-01-15
ZA200309680B (en) 2004-12-22
EP1275377B1 (en) 2003-06-18
CA2452386A1 (en) 2003-01-23
NZ530473A (en) 2006-02-24
DE60100389D1 (de) 2003-07-24
KR20040018440A (ko) 2004-03-03
HRP20040010A2 (en) 2004-06-30
ES2199202T3 (es) 2004-02-16

Similar Documents

Publication Publication Date Title
HRP20040010A2 (en) Granulates containing liposoluble substances and a process for the preparation thereof
WO2003000014A3 (en) Spherical protein particles and methods of making and using them
WO1998041188A3 (en) Stable particle in liquid formulations
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
WO2001032132A3 (en) Process for making toothpaste using agglomerated dispersible polymers
AU5523599A (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
EP1206928A4 (en) WATER-CONTAINING POWDER PREPARATION, METHOD FOR THE PRODUCTION THEREOF, AND COSMETIC PREPARATION THEREOF
HUT75247A (en) Solid pharmaceutical composition comprising an excipient capable of binding water and process for its production
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
AU1850302A (en) Powdery preparations and proecss for producing the same
PT1166645E (pt) Amido aglomerado e produto a base de maltodextrina para a preparacao de alimentos
DE69939555D1 (de) Granuliertes Brotverbesserungmittel zur Herstellung von Teigwaren
WO2000030953A3 (de) Mischkapsel
CA2287333A1 (en) Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
DE50106179D1 (de) Carotinoidtrockenpulver mit einer Multi-Kern Struktur
PT1229900E (pt) Formulacoes de farmacos de libertacao prolongada para implantacao
RU2001100615A (ru) Способ применения костного цемента с биологически активными веществами
EA200200866A1 (ru) Диспергирующийся и быстро гидратирующийся биополимер
ES2171145A1 (es) Formulacion aceleradora de la descomposicion de materia organica en general y de restos animales en particular; procedimiento para su preparacion y aplicaciones.
Jiang et al. Gray System Study on the Influence of Particle Size Distribution of Fly Ash on Strength of Fly Ash Cement
Umirzakov et al. Electronic spectroscopic analysis of surface state of multicomponent systems created by ion implantation; Ehlektronno-spektroskopicheskij analiz sostoyaniya poverkhnosti mnogokomponentnykh sistem, sozdannykh ionnoj implantatsiej

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120709